The Effects of DHA on Attention Deficit and Hyperactivity Disorder

Clinical trial NCT01796262 · COMPLETED

Trial details

NCT number: NCT01796262
Sponsor: IRCCS Eugenio Medea
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Attention Deficit Hyperactivity Disorder

Start date: 2012-06-01
Primary completion: 2015-02-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.